Delivery Order SPE2DE21D7020-SPE2D625F9CB0
- Not listed
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $1,303.44 by the Defense Health Agency's Medical Supply Chain program. This fixed-price contract with economic price adjustment, issued on July 28, 2025, is scheduled for completion by August 4, 2025. The award represents a non-set-aside competitive procurement, with performance occurring at Boston Scientific's Marlborough facility. As a...
- Boston Scientific Corp, a Marlborough, Massachusetts-based global medical technology company, was awarded a delivery order by the Defense Health Agency's Medical Supply Chain on July 22, 2025, with an ultimate completion date of July 29, 2025. The contract, valued at $1,727.26, is structured as a fixed price agreement with economic price adjustment provisions and carries no set-aside designation, indicating open competition in the federal marketplace. The award description references medical...
- Boston Scientific Corp has been awarded a $2,748.80 fixed-price delivery order (Contract No. 4568920509) by the Defense Health Agency's Medical Supply Chain program, with performance to be completed by August 5, 2025. The contract, which carries an economic price adjustment clause, will be performed at the company's Marlborough, Massachusetts location. This delivery order represents Boston Scientific's continued role as a critical supplier of specialized medical devices and equipment to...
- Boston Scientific Corp has been awarded a delivery order valued at $1,639.08 under contract number INTERLOCK 35 by the Defense Health Agency's Medical Supply Chain, a defense-focused federal entity. The contract is a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of August 5, 2025, just one week after the award date of July 29, 2025. Performance will take place at Boston Scientific's facility in Marlborough, Massachusetts. This...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $6,063.45 for medical supply chain support through the Defense Health Agency's Medical Supply Chain. The contract, awarded on July 29, 2025, with an ultimate completion date of August 5, 2025, operates under a fixed-price structure with economic price adjustment provisions. This delivery order is not set aside for any specific business category, allowing Boston Scientific to compete...
- Boston Scientific Corp has been awarded a delivery order valued at $2,458.62 under the Defense Health Agency's Medical Supply Chain program, with an ultimate completion date of August 5, 2025. This contract, designated as INTERLOCK 35, is structured as a fixed-price agreement with economic price adjustment provisions and carries no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The place of performance is Boston Scientific's facility in...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $1,341.85 by the Defense Health Agency's Medical Supply Chain on July 21, 2025. This fixed-price contract with economic price adjustment provisions is designated as contract number 4568850340 for NC EMERGE MR 20MM equipment, with an ultimate completion date of July 28, 2025. The award represents no set-aside designation, allowing Boston Scientific...
- Boston Scientific Corp has been awarded a delivery order valued at $12,397.96 for medical supplies under the Defense Health Agency's Medical Supply Chain program. The contract, designated as a fixed-price agreement with economic price adjustment provisions, was awarded on July 28, 2025, with an ultimate completion date of August 4, 2025. The work will be performed in Marlborough, Massachusetts, where Boston Scientific maintains its headquarters. This delivery order was not set aside for any...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $19,473.05 under the Defense Health Agency's Medical Supply Chain program. Issued on July 30, 2025, with an ultimate completion date of August 6, 2025, this fixed-price delivery order with economic price adjustment carries no set-aside designation, indicating open competition. The contract is titled "ENROUTE NPS PLUS" and will be performed at...
- Boston Scientific Corp has been awarded a delivery order valued at $2,762.81 by the Defense Health Agency's Medical Supply Chain division, with an ultimate completion date of August 8, 2025. This fixed-price contract with economic price adjustment represents a non-set-aside award to the prime contractor, with performance taking place at Boston Scientific's headquarters in Marlborough, Massachusetts. As a global medical technology company, Boston Scientific provides critical medical devices and...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F9CB0Delivery Order
Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a $3,201.54 fixed-price delivery order (Contract No. 4568919661, designated INTERLOCK 35) by the Defense Health Agency's Medical Supply Chain program. The delivery order, effective through August 5, 2025, represents a continuation of Boston Scientific's role as a critical supplier of advanced medical devices to federal healthcare agencies. This non-set-aside award reflects the company's established capability to provide specialized medical technologies, including cardiovascular intervention tools, implantable devices, and diagnostic equipment. The work will be performed at the company's primary facility in Marlborough, Massachusetts. This delivery order is issued under Boston Scientific's existing federal contract vehicles with the Defense Health Agency, which include a single-award Blanket Purchase Agreement valued at $750,000 through March 30, 2030, for radiation treatment devices. The company maintains a robust portfolio of federal contracts across multiple healthcare agencies, including the Department of Veterans Affairs and Defense Logistics Agency, demonstrating its established position as a prime contractor capable of supporting the federal medical supply chain. The economic price adjustment provision allows for cost adjustments based on specified economic indices, providing flexibility in managing the delivery of critical medical technologies to defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 7/29/25 |